Case-control study of breast cancer in India: Role of PERIOD3 clock gene length polymorphism and chronotype

Cancer Invest. 2014 Aug;32(7):321-9. doi: 10.3109/07357907.2014.919305. Epub 2014 Jun 6.

Abstract

Background: This study examined a PERIOD3 (PER3) gene variable number tandem repeat polymorphism and chronotype as potential BrCA risk factors among Indian women.

Methods: This case-control study included sporadic, histologically confirmed BrCA cases (n = 255) and controls (n = 249) from India with data collection from 2010-2012.

Results: Women with the 4/5 or 5/5 PER3 genotype had a nonstatistically significant 33% increased odds of BrCA. Cases were more likely to have a morning (OR = 2.43, 95% CI = 1.23-4.81) or evening (OR = 2.55, 95% CI = 1.19-5.47) chronotype.

Conclusions: Findings are consistent with the possibility that extremes in chronotype may elicit circadian desynchronization, resulting in increased BrCA susceptibility.

Keywords: Breast Cancer; Circadian; Clock Gene; Diurnal Preference.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Breast Neoplasms / epidemiology
  • Breast Neoplasms / genetics*
  • Case-Control Studies
  • Circadian Rhythm / genetics*
  • Female
  • Humans
  • India / epidemiology
  • Middle Aged
  • Nuclear Proteins / genetics
  • Period Circadian Proteins / genetics*
  • Polymorphism, Genetic
  • Risk Factors
  • Surveys and Questionnaires
  • Tandem Repeat Sequences / genetics

Substances

  • Nuclear Proteins
  • PER3 protein, human
  • Period Circadian Proteins